Analytical Data
-
Gene name
MYF6
- Application
-
Alternative Names
bHLHc4; Class C basic helix-loop-helix protein 4; CNM3; HERCULIN; MRF4; Muscle-regulatory factor 4; Muscle-specific regulatory factor 4; Myf-6; Myf6; MYF6_HUMAN; myogenic factor 6 (herculin); Myogenic factor 6
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P23409
-
Expression Region
1-242 aa
-
AA Sequence
MMMDLFETGS YFFYLDGENV TLQPLEVAEG SPLYPGSDGT LSPCQDQMPP EAGSDSSGEE HVLAPPGLQP PHCPGQCLIW ACKTCKRKSA PTDRRKAATL RERRRLKKIN EAFEALKRRT VANPNQRLPK VEILRSAISY IERLQDLLHR LDQQEKMQEL GVDPFSYRPK QENLEGADFL RTCSSQWPSV SDHSRGLVIT AKEGGASIDS SASSSLRCLS SIVDSISSEE RKLPCVEEVV EK
-
Molecular Weight
26.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYF6, also known as Myogenic Factor 6, is a member of the myogenic regulatory factor (MRF) family, which plays a crucial role in muscle development and differentiation. Research on MYF6 has gained prominence due to its significant involvement in myogenesis—the process by which skeletal muscle cells are formed. Understanding the molecular mechanisms of MYF6 can provide insights into muscle regeneration, growth, and repair, making it a key target for therapeutic interventions in muscle-wasting diseases and other conditions affecting muscle integrity. Moreover, MYF6 expression is often examined in various contexts, including embryonic development and response to injury, highlighting its potential in regenerative medicine. The recombinant production of MYF6 protein facilitates the study of its functional properties, interactions, and regulatory pathways, enabling researchers to explore its roles in muscle biology more effectively. Advances in biotechnological methods for protein expression and purification have made it feasible to analyze MYF6 in vitro and in vivo, paving the way for novel strategies in the treatment of muscular disorders. Given the increasing prevalence of such disorders, investigations into MYF6 not only enrich our understanding of muscle biology but also contribute to the development of innovative therapeutic approaches aimed at enhancing muscle health and functionality.
